These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9452320

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis.
    Sampaio C, Coelho T, Castro-Caldas A, Bastos-Lima A, Levy A.
    J Neural Transm Suppl; 1995; 45():197-202. PubMed ID: 8748626
    [Abstract] [Full Text] [Related]

  • 24. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Brücke T, Podreka I, Angelberger P, Wenger S, Topitz A, Küfferle B, Müller C, Deecke L.
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G, Gratz KF, Kolbe H, Meyer GJ, Dengler R, Knoop BO, Hundeshagen H.
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
    Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL.
    Nucl Med Commun; 1994 Oct; 15(10):806-13. PubMed ID: 7838444
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C, Diem A, Jaschke W, Wenning GK, Poewe W.
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [Abstract] [Full Text] [Related]

  • 31. Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study.
    Pizzolato G, Cagnin A, Rossato A, Chierichetti F, Fabbri M, Dam M, Ferlin G, Battistin L.
    Adv Neurol; 1996 Dec; 69():467-73. PubMed ID: 8615167
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Apomorphine test for dopaminergic responsiveness: a dose assessment study.
    Bonuccelli U, Piccini P, Del Dotto P, Rossi G, Corsini GU, Muratorio A.
    Mov Disord; 1993 Apr; 8(2):158-64. PubMed ID: 8474482
    [Abstract] [Full Text] [Related]

  • 34. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB, Jones DW, Coppola R, Hyde TM, Lee KS, Gorey J, Weinberger DR.
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [Abstract] [Full Text] [Related]

  • 35. The relationship between cerebral vascular disease and parkinsonism: The VADO study.
    Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP.
    Parkinsonism Relat Disord; 2012 Jul; 18(6):775-80. PubMed ID: 22531611
    [Abstract] [Full Text] [Related]

  • 36. Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism.
    Schwarz J, Kraft E, Vogl T, Arnold G, Tatsch K, Oertel WH.
    Neuroradiology; 1999 Feb; 41(2):124-8. PubMed ID: 10090605
    [Abstract] [Full Text] [Related]

  • 37. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M, Saéz D.
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [Abstract] [Full Text] [Related]

  • 38. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A, Westera G, Sutter M, Albani C, Kung HF, vonSchulthess GK.
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [Abstract] [Full Text] [Related]

  • 39. Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation.
    Hwang WJ, Yao WJ, Wey SP, Shen LH, Ting G.
    Eur Neurol; 2002 Jul; 47(2):113-7. PubMed ID: 11844900
    [Abstract] [Full Text] [Related]

  • 40. [Efficacy of the proteic redistribution diet (PRD) in the antiparkinsonian effect of L-dopa].
    Duarte J, Moreno C, Coria F, Pérez A, Clavería LE.
    Neurologia; 1993 Oct; 8(8):248-51. PubMed ID: 8240836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.